OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma
Guanghui Hou, Junmin Qian, Min Guo, et al.
Journal of Colloid and Interface Science (2022) Vol. 628, pp. 968-983
Closed Access | Times Cited: 14

Showing 14 citing articles:

Metal‐based smart nanosystems in cancer immunotherapy
Ying Luo, Xiaojing He, Qianying Du, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 23

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8

Chitosan coated pH/redox-responsive hyaluronic acid micelles for enhanced tumor targeted co-delivery of doxorubicin and siPD-L1
Panpan Song, Zhongxia Lu, Tianze Jiang, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1078-1091
Closed Access | Times Cited: 25

Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma
Shiji Fang, Liyun Zheng, Gaofeng Shu, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8811-8826
Closed Access | Times Cited: 4

Redefining Hepatocellular Carcinoma Treatment: Nanotechnology Meets Tumor Immune Microenvironment
Chen Mi, Sai Liu, Zhida Chen
Journal of drug targeting (2025), pp. 1-47
Closed Access

Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 3

A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy
Jingrong Zhou, Yunping Hu, Yuhua Cao, et al.
Journal of Colloid and Interface Science (2024) Vol. 660, pp. 869-884
Closed Access | Times Cited: 2

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 2

Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments
Rongwei Xu, Pei Lin, Jiarong Zheng, et al.
Materials Today Bio (2024) Vol. 30, pp. 101386-101386
Closed Access | Times Cited: 2

Design of manganese-based nanomaterials for pharmaceutical and biomedical applications
Poonam Jain, Ashok Kumar Jangid, Deep Pooja, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 3, pp. 577-608
Closed Access | Times Cited: 4

Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma
Qiaoyun Liu, Wei Huang, Wenjin Liang, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2211-2211
Open Access | Times Cited: 3

Progress in Research on Immunogenic Cell Death and Its Application in Hepatocellular Carcinoma Therapy
辰宇 巩
Advances in Clinical Medicine (2024) Vol. 14, Iss. 09, pp. 1025-1033
Closed Access

Page 1

Scroll to top